---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-002694"
form_type: "8-K"
ticker: "ACRS"
cik: "0001557746"
company_name: "Aclaris Therapeutics, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:51:44.529990+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aclaris Therapeutics files 8-K furnishing updated corporate overview; no new financial data disclosed

## Summary
- Filed Form 8-K on Jan. 12, 2026, updating its corporate overview presentation (Exhibit 99.1).
- Presentation available on company website; no specific financial or operational changes provided in filing.
- No earnings, guidance, clinical results, or other material events disclosed in the filing or exhibit.

## SEC filing metadata
- accession: 0001104659-26-002694
- form_type: 8-K
- ticker: ACRS
- cik: 0001557746
- company_name: Aclaris Therapeutics, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557746/000110465926002694/0001104659-26-002694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557746/000110465926002694/acrs-20260112x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-002694
- JSON: https://secwatch.observer/filing/0001104659-26-002694.json
- Plain text: https://secwatch.observer/filing/0001104659-26-002694.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.